Unknown OBSERVATIONAL NCT06025604

ACTIVPROSEIN : Professional Activity After Breast Cancer

Psycho Social Factors Associated to Return to Work After Breast Cancer Care : a Prognostic Study

Sponsor: University Hospital, Grenoble

Conditions Breast Cancer Female Return to Work

Updated 4 times since 2023 Last updated: Sep 14, 2023 Started: Sep 14, 2023 Primary completion: Sep 13, 2025 Completion: Sep 13, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06025604, this observational or N/A phase trial focuses on Breast Cancer Female and Return to Work and remains ongoing. Sponsored by University Hospital, Grenoble, it has been updated 4 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Nov 2025 — Present [monthly]

Unknown

Status: Recruiting → Unknown
Sep 2024 — Nov 2025 [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Oct 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Sep 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Grenoble

Data source: University Hospital, Grenoble

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Grenoble, France